Frontiers in Immunology (Jun 2024)
Corrigendum: Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer
- Huijing Feng,
- Siyuan Zhang,
- Siyuan Zhang,
- Siyuan Zhang,
- Siyuan Zhang,
- Siyuan Zhang,
- Qiuru Zhou,
- Qiuru Zhou,
- Qiuru Zhou,
- Qiuru Zhou,
- Qiuru Zhou,
- Qiuru Zhou,
- Fei Han,
- Gang Du,
- Lin Wang,
- Xuena Yang,
- Xuena Yang,
- Xuena Yang,
- Xuena Yang,
- Xuena Yang,
- Xiying Zhang,
- Xiying Zhang,
- Xiying Zhang,
- Xiying Zhang,
- Xiying Zhang,
- Wenwen Yu,
- Wenwen Yu,
- Wenwen Yu,
- Wenwen Yu,
- Wenwen Yu,
- Feng Wei,
- Feng Wei,
- Feng Wei,
- Feng Wei,
- Feng Wei,
- Feng Wei,
- Xishan Hao,
- Xishan Hao,
- Xishan Hao,
- Xishan Hao,
- Xishan Hao,
- Xiubao Ren,
- Xiubao Ren,
- Xiubao Ren,
- Xiubao Ren,
- Xiubao Ren,
- Xiubao Ren,
- Xiubao Ren,
- Hua Zhao,
- Hua Zhao,
- Hua Zhao,
- Hua Zhao,
- Hua Zhao,
- Hua Zhao
Affiliations
- Huijing Feng
- Department of Thoracic Oncology, Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
- Siyuan Zhang
- National Clinical Research Center for Cancer, Tianjin, China
- Siyuan Zhang
- Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
- Siyuan Zhang
- Tianjin’s Clinical Research Center for Cancer, Tianjin, China
- Siyuan Zhang
- Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China
- Siyuan Zhang
- Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Qiuru Zhou
- National Clinical Research Center for Cancer, Tianjin, China
- Qiuru Zhou
- Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
- Qiuru Zhou
- Tianjin’s Clinical Research Center for Cancer, Tianjin, China
- Qiuru Zhou
- Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China
- Qiuru Zhou
- Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Qiuru Zhou
- Wenzhou Central Hospital, Wenzhou, Zhejiang, China
- Fei Han
- Department of head and neck surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China
- Gang Du
- Department of Pathology, Shanxi Bethune Hospital, Taiyuan, Shanxi, China
- Lin Wang
- 0General Surgery Department, Shanxi Bethune Hospital, Taiyuan, Shanxi, China
- Xuena Yang
- National Clinical Research Center for Cancer, Tianjin, China
- Xuena Yang
- Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
- Xuena Yang
- Tianjin’s Clinical Research Center for Cancer, Tianjin, China
- Xuena Yang
- Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China
- Xuena Yang
- Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Xiying Zhang
- National Clinical Research Center for Cancer, Tianjin, China
- Xiying Zhang
- Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
- Xiying Zhang
- Tianjin’s Clinical Research Center for Cancer, Tianjin, China
- Xiying Zhang
- Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China
- Xiying Zhang
- Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Wenwen Yu
- National Clinical Research Center for Cancer, Tianjin, China
- Wenwen Yu
- Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
- Wenwen Yu
- Tianjin’s Clinical Research Center for Cancer, Tianjin, China
- Wenwen Yu
- Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China
- Wenwen Yu
- Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Feng Wei
- National Clinical Research Center for Cancer, Tianjin, China
- Feng Wei
- Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
- Feng Wei
- Tianjin’s Clinical Research Center for Cancer, Tianjin, China
- Feng Wei
- Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China
- Feng Wei
- Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Feng Wei
- 1Haihe Laboratory of Cell Ecosystem, Tianjin, China
- Xishan Hao
- National Clinical Research Center for Cancer, Tianjin, China
- Xishan Hao
- Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
- Xishan Hao
- Tianjin’s Clinical Research Center for Cancer, Tianjin, China
- Xishan Hao
- Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China
- Xishan Hao
- 1Haihe Laboratory of Cell Ecosystem, Tianjin, China
- Xiubao Ren
- National Clinical Research Center for Cancer, Tianjin, China
- Xiubao Ren
- Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
- Xiubao Ren
- Tianjin’s Clinical Research Center for Cancer, Tianjin, China
- Xiubao Ren
- Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China
- Xiubao Ren
- Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Xiubao Ren
- 1Haihe Laboratory of Cell Ecosystem, Tianjin, China
- Xiubao Ren
- 2Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Hua Zhao
- National Clinical Research Center for Cancer, Tianjin, China
- Hua Zhao
- Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
- Hua Zhao
- Tianjin’s Clinical Research Center for Cancer, Tianjin, China
- Hua Zhao
- Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China
- Hua Zhao
- Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Hua Zhao
- 1Haihe Laboratory of Cell Ecosystem, Tianjin, China
- DOI
- https://doi.org/10.3389/fimmu.2024.1397764
- Journal volume & issue
-
Vol. 15
Abstract
No abstracts available.Keywords
